All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
How should we use geriatric assessment to guide treatment decisions for elderly patients with DLBCL?
Featured
Bookmark this article
During the 61st American Society of Hematology (ASH) meeting in Orlando, US, the Lymphoma Hub was pleased to speak to Stefano Luminari, University of Modena, Reggio Emilia, IT. We asked: How should we use geriatric assessment to guide treatment decisions for elderly patients with diffuse large B-cell lymphoma?
Stefano Luminari talks about the high incidence of DLBCL in elderly patients. The complexity of the management of this patient population, such as the high risk of comorbidity and toxicity, makes it challenging to select the right treatment option. Therefore the geriatric assessment tools are welcome. He discusses such tools that are presented at the ASH 2019 meeting.
How should we use geriatric assessment to guide treatment decisions for elderly patients with DLBCL?
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Thank youRelated articles
Newsletter
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox